This week, we dissect the critical Class I recall of Olympus's High Flow Insufflation Units. We move beyond the headlines to explore the immense operational challenges and regulatory complexities of executing a global recall, highlighting the often-underestimated importance of a proactive Post-Market Surveillance (PMS) system.

This episode is a must-listen for any MedTech professional who wants to understand the real-world consequences of a product failure. We reveal the hidden logistical nightmare that unfolds when a safety signal in one market triggers a worldwide crisis, showing how a lack of preparation can lead to devastating financial and reputational damage.

Key Takeaways:

- What are the non-obvious signs that your PMS system is reactive, not proactive?

- How can a single patient complaint in one country escalate into a global recall?

- Are you prepared to manage the distinct reporting requirements of the FDA, EMA, and other bodies simultaneously?

- What is the most common mistake companies make when initiating a corrective action plan?

- How does your designated local representative impact your ability to respond to a crisis effectively?

- Beyond regulatory fines, what are the hidden operational costs of a poorly managed recall?

- Is your technical documentation structured to support a rapid global investigation?

For help navigating these challenges, contact us at [email protected], visit https://pureglobal.com/, or access our FREE AI tools and medical device database at https://pureglobal.ai/.